Monographie - Thiopental sodium

Poslední aktualizace :
19/11/2024

Thiopental sodium

Chemický vzorec

Obchodní název

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Anapental	Egypt
Anental	Kolumbie, Venezuela
Epental	Saúdská Arábie
Exipental	Írán
Farmotal	Itálie
Gabapentax	Kolumbie
Hipnopento	Argentina
Nesdonal	Nizozemsko
Pantul	Ekvádor, Peru
Pensodital	Mexiko
Pental	Turecko
Pentarim	Mexiko
Pentax	Venezuela
Pentocur	Island, Norsko
Pentotex	Malajsie
Pentothal	Austrálie, Belgie, Dánsko, Finsko, Itálie, Kanada, Lucembursko, Mexiko, Švédsko, Švýcarsko, ÿecko
Sodipental	Kolumbie, Mexiko
Thiojex	Chile
Thiomek	Peru
Thiopental	Egypt, Francie, Írán, Irsko, Malajsie, MaÔarsko, Maroko, NÏmecko, Polsko, Rakousko, Rumunsko, Saúdská Arábie, Tunisko, Velká Británie, ÿecko
Thiopentax	Ekvádor, Venezuela
Tiobarbital	äpanÏlsko, Kolumbie
Trapanal	NÏmecko
Zedisol	Mexiko

Odkazy : Thiopental sodium

	typ	uveřejnění
59	noviny	Trissel LA, Gilbert DL, Martinez JF, Kim MC. Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
125	noviny	Chernin EL, Stewart JT, Smiler B. Stability of thiopental sodium and propofol in polypropylene syringes at 23 and 4°C. Am J Health-Syst Pharm 1996 ; 53: 1576-1579.
126	noviny	Prankerd RJ, Jones RD. Physicochemical compatibility of propofol with thiopental sodium. Am J Health-Syst Pharm 1996 ; 53: 2606-2610.
299	noviny	Trissel LA, Martinez JF, Gilbert DL. Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
314	noviny	Chiu MF, Schwartz ML. Visual compatibility of injectable drugs used in the intensive care unit. Am J Health-Syst Pharm 1997 ; 54: 64-65.
319	noviny	Hadzija BW, Lubarsky DA. Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia. Am J Health-Syst Pharm 1995 ; 52: 997-999.
350	noviny	Martens HJ, De Goede PN, Van Loenen AC. Sorption of various drugs in polyvinyl chloride, glass, and polyethylene-lined infusion containers. Am J Hosp Pharm 1990 ; 47: 369-373.
527	noviny	Das Gupta V, Neal Gardner S, Jolowsky CM, Newcomer DR, Stewart KR. Chemical stability of thiopental sodium injection in disposable plastic syringes. J Clin Pharm Ther 1987 ; 12: 339-342.
642	noviny	Baumgartner TG, Knudsen AK, Dunn AJ, Kilroy RA. Norepinephrine stability in saline solutions. Hosp Pharm 1988 ; 23: 44,49, 59.
755	Laboratoř	Pancuronium (Pavulon®) - Résumé des caractéristiques du produit MSD France 2016
871	noviny	Haws JL, Herman N, Clark Y, Bjoraker R, Jones D. The chemical stability and sterility of sodium thiopental after preparation. Anesth Analg 1998 ; 86: 208-213.
919	noviny	Lazar ER, Jolly DT, Tam YK, Hrazdil J, Tawfik SR, Clanachan AS. Propofol and thiopental in a 1:1 volume mixture is chemically stable. Anesth Analg 1998 ; 86: 422-426.
1173	noviny	Kowaluk EA, Roberts MS, Blackburn HD, Polack AE. Interactions between drugs and polyvinyl chloride infusion bags. Am J Hosp Pharm 1981 ; 38: 1308-1314.
1713	noviny	Trissel LA, Saenz CA. Compatibility screening of bivalirudin during simulated Y-site administration with other drugs. Int J Pharm Compound 2002 ; 6: 311-315.
1721	noviny	Trissel LA, Williams KY, Baker MB. Compatibility screening of Hextend during simulated Y-site administration with other drugs. Int J Pharm Compound 2001 ; 5: 69-72.
1803	noviny	Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB. Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2003 ; 60: 80-85.
2073	noviny	Taniguchi T, Yamamoto K, Kobayashi T. Precipitate formed by thiopentone and vecuronium causes pulmonary embolism. Can J Anesth 1998 ; 45: 347-351.
2079	noviny	Morton WD, Lerman J. The effect of pancuronium on the solubility of aqueous thiopentone. Can J Anesth 1987 ; 34: 87-89.
2090	noviny	Pere H, Chasse V, Forest JM, Hildgen P. Compatibility of injectable pantoprazole in Y-site administration. Pharmactuel 2004 ; 37: 193-196.
2105	noviny	Valverde molina F, Hernandez Hernandez G, Munoz Castillo M, Novales Duran J, Gallego Fernandez C. Estabilidad de una mezcla de etomidato y pentotal para administracion intravenosa en bolo. Farm Hosp 1999 ; 23: 357-360.
2146	noviny	Trissel LA, Xu QA, Baker M. Drug compatibility with new polyolefin infusion solution containers. Am J Health-Syst Pharm 2006 ; 63: 2379-2382.
2231	noviny	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3134	noviny	Perez Jua En, Maqueda Palau M, Arévalo Rubert Mt, Ribas Nicolau B, Amoros Cerdà SM. Compatibilidad visual y física de la furosemida en mezclas intravenosas para perfusión continua. Enferm Intensiva 2010 ; 21: 96-103.
3212	noviny	Ribas Nicolau, B.; P?rez Juan, E.; Amor?s Cerd?, S.M.; Ar?valo Rubert, M.J.; Maqueda Palau, M. Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos. Enferm Intensiva 2011 ;22:78-82.
3372	noviny	Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S. Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine. Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3373	noviny	Khan S, Stannard N, Greijn J. Precipitation of thiopental with muscle relaxants: a potential hazard. J R Soc Med Sh Rep 2011 ; 2: 58.
3377	noviny	Huddy NC, Durcan JJ. Precipitation betwen meptazinol and thiopentone. Anaesthesia 1983 ; 38: 601-602.
3408	noviny	Tollec S, Touzin K, Pelletier E, Forest J.M. Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels. Pharmactuel 2013 ; 46, 1 : 16-21.
3464	noviny	Monica Maqueda-Palau, Eva Pérez-Juan, Maria Josep Arévalo-Rubert, Sylvia Monica Amoros-Cerda, Bàrbara Ribas-Nicolau. Compatibilidad física de la amiodarona en perfusión continua Enferm Clin 2011 21:25-29.
3466	noviny	B. Ribas Nicolau, E. P?rez Juan, S.M. Amor?s Cerd?, M.J. Ar?valo Rubert, M. Maqueda Palau. Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos Enferm Intensiva 2011 ;22:78-82.
3501	Laboratoř	Ketamine hydrochloride (Ketalar®) - Summary of Product Characteristics Pfizer 2011
3503	Laboratoř	Fentanyl - Summary of product Characteristics Hameln Pharmaceuticals 2012
3525	Laboratoř	Pethidine hydrochloride - Summary of product Characteristics AMCO Amdipharm Mercury 2012
3526	Laboratoř	Clindamycin (Dalacin®) - Summary of Product Characteristics Pharmacia 2010
3531	Laboratoř	Morphine sulphate 10 mg/mL injection BP – Summary of Product Characteristics Wockhardt 2014
3549	Laboratoř	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3564	Laboratoř	Rocuronium B Braun - Résumé des caractéristiques du produit. B Braun 2012
3599	Laboratoř	Glycopyrrolate Injection U.S.P. - Summary of Product Characteristics Amco Amdipharm Mercry 2013
3600	Laboratoř	Hydroxyzine (Atarax®) - Résumé des caractéristiques du produit UCB Pharma SA 2009
3601	Laboratoř	Cisatracurium Actavis - Résumé des Caractéristiques du Produit Actavis 2012
3607	Laboratoř	Esmolol hydrochloride for injection - Summary of Product Characteristics AOP Orphan Pharmaceuticals AG 2013
3612	Laboratoř	Doxapram (Dopram) - Summary of Product Characteristics Amdipharm Mercury Company 2012
3614	Laboratoř	Nicardipine Injection - Summary of Product Characteristics American Regent Inc 2013
3629	Laboratoř	Atracurium (Atracurium solution for injection/infusion®) - Summary of Product Characteristics Actavis UK 2014
3630	Laboratoř	Vecuronium (Norcuron®) - Summary of Product Characteristics Merck Sharp Dohme 2012
3631	Laboratoř	Suxamethonium (Suxamethonium Aguettant®) - Résumé des caractéristiques du produit Aguettant 2016
3674	Laboratoř	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3675	Laboratoř	Thiopental sodium - Summary of Product Characteristics Archimedes Pharma UK Ltd 2015
3676	Laboratoř	Atracurium bésilate (Atracurium Hospira®) - Résumé des caractéristiques du produit Hospira 2014
3767	noviny	Legris M.E, Lavoie A, Forrest J.M, Hildgen P. Compatibilité par évaluation visuelle du thiopental injectable lors de son administration en Y avec des médicaments usuels. Pharmactuel 2014 ; 47, 3 : 167-172.
3823	noviny	Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R. Compatibilité physique de médicaments administrés dans l’unité de soins intensifs Pharmactuel 2015 ; 48, 3 : 146-152.
3932	Laboratoř	Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit Serb Laboratoire 2015
3941	Laboratoř	Nicardipine - Summary of Product Characteristics Concordia International 2017
4009	Laboratoř	Droperidol - Résumé des Caractéristiques du Produit Panpharma 2017
4428	noviny	Rashed S.M, Sweatman T.W, Thoma L, Hovinga C.A, Phelps S.J. Chemical Compatibility of Depacon® with Medications Frequently Administered by Intravenous Y-Site Delivery in Patients with Epilepsy or Head Trauma. J Pediatr Pharmacol Ther 2004 ; 9, 2: 126-132.
4700	Laboratoř	Esketamine 25 mg/mL solution for injection/infusion. - Summary of Product Characteristics AS Kalceks 2022

Mentions Légales